- Novel, intuitive software and touchscreen interface provide results in only a few steps
- Validated assays provide rapid answers on cell concentration, viability, measurement of apoptotic status and cell cycle
- Simple, effortless operation in a low cost platform
Billerica, MA—December 5, 2011—EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, today announced launch of the innovative Muse™ Cell Analyzer system for real-time quantitative assessment of cell concentration, cell health, apoptosis, and cell cycle with greater accuracy and precision than manual hemocytometry or image-based automated analysis.
By providing real-time, multi-dimensional information on cell populations, the Muse™ cell analyzer enables faster, more accurate decision-making, more productive workflows, and greater insight in to cell health.
The Muse™ system delivers high-performance cell analysis using patent-pending, miniaturized fluorescent detection and microcapillary technology which occupy one-tenth the space of a typical cytometer. Laser-based fluorescence detection of each cell event can evaluate up to three cellular parameters. As a result, Muse™ provides accurate quantitative results compared to imaging-based systems, which only examine up to two parameters, are time-consuming and ultimately provide less quantitative data. The system is capable of analyzing both suspension and adherent cells from two to sixty μm in diameter. Intuitive software and simple touchscreen interface enable rapid set-up and analysis.
“The Muse™ system occupies an important place in our line of cell analysis platforms and delivers unique benefits to researchers,” describes John Sweeney, Head of Life Science Business Field, EMD Millipore. “With Muse™, researchers can gain new insights into cell health with greater precision and accuracy than they have come to experience with existing cell analysis techniques and instruments, without the price barrier as the system is priced just above $12,000.”
To further optimize workflows, the Muse™ Cell Analyzer is designed to work with all-in-one kits, specifically validated for robust performance on the system. Kits include cell count and viability, apoptosis and cell cycle and come with all the reagents necessary for proper sample preparation.
For more information on Muse™ and the full line of cellular analysis platforms from EMD Millipore, please visit www.millipore.com/muse.
About EMD Millipore
EMD Millipore is the Life Science division of Merck KGaA of Germany and offers a broad range of innovative, performance products, services and business relationships that enable our customers' success in research, development and production of biotech and pharmaceutical drug therapies. Through dedicated collaboration on new scientific and engineering insights, and as one of the top three R&D investors in the Life Science Tools industry, EMD Millipore serves as a strategic partner to customers and helps advance the promise of life science.
Headquartered in Billerica, Massachusetts, the division has around 10,000 employees, operations in 67 countries and 2010 revenues of $2.2 billion. EMD Millipore is known as Merck Millipore outside of the U.S. and Canada.
Note: Merck KGaA or Merck shall mean Merck KGaA, Darmstadt, Germany
Contact:
Leslie Eisenberg (Feinstein Kean Healthcare)
Phone: +1 617 244 3872
Email: [email protected]